|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| Equity in income of unconsolidated entities | |||||
| Distributions of earnings from unconsolidated entities | |||||
| Depreciation and amortization | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale of interest rate cap | |||||
| Gain on disposal of assets | |||||
| Compensation expense for equity awards | |||||
| Inventory impairment | |||||
| Deferred income taxes | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Real estate inventory | |||||
| Pre-acquisition costs and deposits | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Investment in unconsolidated entities | |||||
| Return of capital from unconsolidated entities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from notes payable | |||||
| Payments on notes payable | |||||
| Proceeds from financing arrangements | |||||
| Payments on financing arrangements | |||||
| Redemption premium | |||||
| Loan issuance costs | |||||
| Proceeds from sale of stock, net of offering expenses | |||||
| Stock repurchase | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period |
Loading...